Flow cytometric and IHC analyses (Fig. 2c–f) demonstrated dose-dependent binding of CSPG4 IgE to human melanoma cell lines known to express human CSPG4 (A2058, A375, WM1366)5,34. This evidence concerns the gene CSPG4 and melanoma.